Recombinant Human CD19-Fc Chimera (carrier-free) 100 µg
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
CD19 is a 95 kD transmembrane glycoprotein that functions as a co-receptor for the B-cell antigen receptor (BCR) complex on B lymphocytes. CD19 is expressed throughout B cell development, and it is commonly used as a B-cell lineage marker. CD19 plays an important role in B-cell activation and humoral immune responses. It is required for the responsiveness of mature B cells to antigen stimulation, germinal center development, and antibody affinity maturation. CD19's association with the BCR, CD81, CD38, CD21, CD22, and IFITM1/CD225/Leu13 enables CD19 to amplify B-cell signaling and decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. CD19 activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca2+ stores. CD19 polymorphisms are associated with the development of autoimmunity by promoting autoantibody production. Homozygous mutations in CD19 cause a type of hypogammaglobulinemia in which the response of mature B cells to antigenic stimulation is defective.;
Garantie
Garantie 0 Mois
Description
CD19 is a 95 kD transmembrane glycoprotein that functions as a co-receptor for the B-cell antigen receptor (BCR) complex on B lymphocytes. CD19 is expressed throughout B cell development, and it is commonly used as a B-cell lineage marker. CD19 plays an important role in B-cell activation and humoral immune responses. It is required for the responsiveness of mature B cells to antigen stimulation, germinal center development, and antibody affinity maturation. CD19's association with the BCR, CD81, CD38, CD21, CD22, and IFITM1/CD225/Leu13 enables CD19 to amplify B-cell signaling and decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. CD19 activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca2+ stores. CD19 polymorphisms are associated with the development of autoimmunity by promoting autoantibody production. Homozygous mutations in CD19 cause a type of hypogammaglobulinemia in which the response of mature B cells to antigenic stimulation is defective.;
Caractéristiques
- Fournisseur
- BioLegend Europe BV
- Marque
- BIOLEGEND
- Référence fabricant
- 789006
- Référence distributeur
- 789006
- Vendu par
- 100 μg
- Quantité
- N/A
- Lieu de fabrication
- USA
- Lieu de stockage
- Pays-Bas ou USA
- Soumis à carboglace
- non
- Classement dans le catalogue fournisseur
- Recombinant Protein
- Certification
- RUO
- Type d’application
- bioassay
- Type de produit
- Recombinant Protein
- Température de conservation (°C)
- -20 ou -70 °C
- Température de transport
- Blue Ice
- Organisme cible
- Human
- Source biologique
- CHO cells
- Seuil de coupure des masses moléculaires MWCO
- The 515 amino acid recombinant protein has a predicted molecular mass of approximately 57.5 kD. The DTT-reduced protein migrates at approximately 75 kD and the non-reduced protein migrate at approximately 150 kD by SDS-PAGE. Da
- Concentration
- 10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration, please enter the lot number in our online tools.
- Pureté
- >95%, as determined by Coomassie stained SDS-PAGE. %
- Matière dangereuse
- Non
- Code douanier
- 38220000
- Classement NCBI
- 930
- Nomenclature Nacres
- NA.77
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA77
- Nomenclature CNRS
- NA77
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO
- Reprise en cas d’erreur client
- non